Trial intelligence / Profile preview

Pharmacological treatment of psychotic depression

NL-OMON24572Active, not recruiting

Start
Mar 2002
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in major depressive disorder and Delusional Depression (DD) comparing Venlafaxine monotherapy, Imipramine monotherapy and Venlafaxine + quetiapine (3 arms). Primary endpoint: Proportion of responders. Started Mar 2002; status: active, not recruiting.

02

Drugs

venlafaxineimipraminequetiapine
03

Conditions

major depressive disorderDelusional Depression (DD)

Beyond the preview

Go deeper on NL-OMON24572.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON24572.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call